Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did YD Bio Beat Earnings?

YD Bio (YDES) reported Q4 '24 revenue of $0, with reported EPS of $0.10.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — YD Bio’s job postings, web traffic, and employee business outlook. See the full YDES stock analysis or the earnings calendar for upcoming reports.

YD Bio Quarterly Financial Trends ()

MetricQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q4 '25Q2 '26
Revenue————————
Gross margin————————
Operating margin————————
Net income-22M17M2.2M420,000-3.4M-2.2M——
Net margin————————
EPS—$4.05—$0.10————

YD Bio Earnings Trend Analysis

Over the eight quarters from Q1 '24 to Q2 '26, YD Bio’s quarterly revenue moved from $0 to $0.

When Is YD Bio’s Next Earnings Date?

YD Bio reports earnings on a quarterly schedule. Its most recent report covered Q4 '24. For the confirmed upcoming date — and every other company reporting soon — see the YDES earnings calendar.

Frequently Asked Questions: YD Bio Earnings

YD Bio's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

YD Bio reported Q4 '24 EPS of $0.10 on revenue of $0. YD Bio reported EPS of $0.10.

YD Bio reported Q4 '24 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the YDES AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.